Stay updated on Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page.

Latest updates to the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page
- Check3 days agoChange DetectedUpdated revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' element; no core content, pricing, stock, or time-related information changed.SummaryDifference0.1%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.1%
- Check18 days agoChange DetectedThe web page has been updated to include new facility and publication information related to prostate cancer research, while several previous location and genetic resource details have been removed.SummaryDifference5%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check39 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11.SummaryDifference0.1%
- Check46 days agoChange DetectedThe page has been updated to include a new HHS Vulnerability Disclosure and has been revised to version 2.16.10, replacing the previous version 2.16.6. Additionally, a service alert regarding planned maintenance has been removed.SummaryDifference0.8%
Stay in the know with updates to Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page.